SUPN (Supernus Pharmaceuticals, Inc.) Yalpi foyda normasi

SUPN (Supernus Pharmaceuticals, Inc.) - kompaniyaning tovar belgisi

Supernus Pharmaceuticals (SUPN) energiyani tejovchi texnologiyalarni joriy etmoqda va kimyoviy emissiyalarni qat'iy cheklamoqda. GURU.Markets platformasida prognoz qilingan yalpi marjani tahlil qilib, biz qiymat 85.10 darajasida barqarorlashganini aniqladik, bu esa xarajatlar samaradorligini tasdiqlaydi. Barqaror brend profili shifokorlar va pragmatik investorlar orasida ishonchni uyg'otadi, bemorlarni qo'llab-quvvatlash tizimiga ega bo'lgan noyob CNS dori ekotizimi esa mijozlarning generik dori vositalariga o'tishining oldini oladi.

supernus.com (SUPN) Yalpi rentabellik: 04.07.2022 - 20.11.2026 davri uchun

Supernus Corp (SUPN) moliyaviy va bozor koʻrsatkichlari kesimi

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- biznesning bozor baholash ko'rsatkichlari:
Fundamental baholash:SUPN, Supernus
Supernus Pharma asosiy tovari

Supernus Pharmaceuticals (SUPN) kompaniyasining yopiq markaziy nerv tizimi (CNS) dori vositalari ekotizimi mijozlarning chiqib ketishini minimallashtiradi, bu esa bevosita yuqori ishlab chiqarish samaradorligini ta'minlaydi. Valole foyda ulushi bevosita xarajatlar chegirib tashlanganidan keyingi foyda qismini o'lchaydi, bu esa investorlarga kompaniyaning narx belgilash imkoniyatlarini va pul oqimini yaratish qobiliyatini baholash imkonini beradi. Valole rentabellik tendentsiyalarini tahlil qilish aktivlarning haddan tashqari qizigan nuqtalarini aniqlashga va daromadlar hamda xatarlar o'rtasidagi optimal muvozanatni topishga yordam beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|CPRX - Yalpi rentabellik|Yalpi foyda marjasi Denali Therapeutics|HRMY: Yalpi marja|Biohaven - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik AMLX|Trevi Therapeutics, Inc. (TRVI) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik PRAX (Praxis Medicines)|Anavex Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik CeriBell CBLL|Yalpi foyda bo'yicha sotuv rentabelligi Prothena Biosciences (PRTA)|ALEC: Yalpi foyda bo'yicha rentabellik|ANNX - Yalpi marja|Omeros Corp. (OMER) - Yalpi rentabellik|Yalpi foyda marjasi Neurogene Inc. (NGNE)|Yalpi foyda bo'yicha rentabellik ACIU|Yalpi rentabellik VYGR|Yalpi rentabellik Neumora (NMRA)|SCLX - Yalpi foyda marjasi|Yalpi marja TVGN (Tevogen Bio Holdings Inc.)|Yalpi foyda normasi ACOG|Cognition Therapeutics Inc. - Yalpi marja|IKT - Yalpi marja|SAVA: Yalpi marja|Assertio Holdings, Inc. - Yalpi foyda normasi|COYA (Coya) - Yalpi marja|Sotuvning yalpi rentabelligi VTGN (Vistagen Therapeutics)|Yalpi rentabellik Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)